Empowered Funds LLC Takes $6 Million Position in Agilent Technologies, Inc. $A

Key Points

• Empowered Funds LLC acquired 45,202 Agilent Technologies shares during the second quarter, worth approximately $6 million. Several other institutional investors also initiated or expanded positions.
• Agilent exceeded quarterly expectations, reporting $1.62 in EPS and approximately $1.88 billion in revenue, with revenue up 8.1% year over year. The company issued fiscal 2026 guidance of $6.18–$6.21 EPS.
• Analysts remain broadly bullish, with a consensus “Moderate Buy” rating and an average price target of $170.33; recent targets range from $175 to $190. However, the stock’s valuation—around 30 times earnings—could leave it vulnerable to slower demand or weaker guidance.

Empowered Funds LLC purchased a new stake in shares of Agilent Technologies, Inc. (NYSE:A - Free Report) during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The fund purchased 45,202 shares of the medical research company's stock, valued at approximately $6,004,000.

A number of other large investors have also recently added to or reduced their stakes in the business. United Capital Financial Advisors LLC purchased a new position in Agilent Technologies in the second quarter worth approximately $817,000. Pacific Heights Asset Management LLC purchased a new stake in Agilent Technologies in the second quarter valued at $19,924,000. Jefferies Financial Group Inc. acquired a new position in shares of Agilent Technologies in the 2nd quarter valued at $8,392,000. Public Employees Retirement System of Ohio acquired a new position in shares of Agilent Technologies in the 2nd quarter valued at $12,433,000. Finally, MASTERINVEST Kapitalanlage GmbH acquired a new position in shares of Agilent Technologies in the 2nd quarter valued at $2,668,000.

Agilent Technologies Price Performance

A stock opened at $154.47 on Monday. The business's fifty day moving average price is $140.30 and its 200 day moving average price is $127.04. Agilent Technologies, Inc. has a 12-month low of $108.35 and a 12-month high of $163.75. The company has a current ratio of 2.05, a quick ratio of 1.56 and a debt-to-equity ratio of 0.50. The company has a market capitalization of $43.63 billion, a PE ratio of 30.41, a P/E/G ratio of 2.34 and a beta of 1.25.

Agilent Technologies (NYSE:A - Get Free Report) last announced its earnings results on Wednesday, August 26th. The medical research company reported $1.62 EPS for the quarter, beating analysts' consensus estimates of $1.49 by $0.13. The company had revenue of $1.88 billion during the quarter, compared to analysts' expectations of $1.84 billion. Agilent Technologies had a return on equity of 24.45% and a net margin of 19.53%.Agilent Technologies's revenue for the quarter was up 8.1% on a year-over-year basis. During the same period last year, the business posted $1.37 EPS. Agilent Technologies has set its Q4 2026 guidance at 1.710-1.740 EPS and its FY 2026 guidance at 6.180-6.210 EPS. On average, sell-side analysts anticipate that Agilent Technologies, Inc. will post 6.2 EPS for the current year.

Analysts Set New Price Targets

A number of analysts recently issued reports on A shares. JPMorgan Chase & Co. raised their price objective on Agilent Technologies from $180.00 to $190.00 and gave the stock an "overweight" rating in a research report on Thursday. Barclays increased their target price on shares of Agilent Technologies from $150.00 to $175.00 and gave the stock an "overweight" rating in a research note on Thursday. Stifel Nicolaus lifted their price target on shares of Agilent Technologies from $170.00 to $180.00 and gave the company a "buy" rating in a research report on Thursday. Wells Fargo & Company reduced their price target on shares of Agilent Technologies from $165.00 to $160.00 and set an "overweight" rating on the stock in a research note on Thursday, May 28th. Finally, Morgan Stanley boosted their price target on shares of Agilent Technologies from $160.00 to $175.00 and gave the company an "overweight" rating in a research note on Wednesday, August 12th. One analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating and four have given a Hold rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average price target of $170.33.

Key Stories Impacting Agilent Technologies

Here are the key news stories impacting Agilent Technologies this week:

• Positive Sentiment: Agilent reported fiscal Q3 earnings of $1.62 per share, above the $1.48-$1.49 analyst consensus, while revenue of approximately $1.88 billion also exceeded expectations. EPS increased from $1.37 a year earlier, supporting the view that profitability is improving. Agilent Technologies Q3 Earnings and Revenues Top Estimates
• Positive Sentiment: Management raised its full-year guidance following the strong quarter. Commentary highlighted product momentum, a recovery in China, improving demand and expanding margins, all of which could support additional earnings growth. Agilent Technologies Lifts Outlook After Strong Quarter
• Positive Sentiment: Several major firms raised their price targets and maintained bullish ratings after the results. Targets now range from $175 to $190, with upgrades from JPMorgan, Citi, Barclays, Goldman Sachs, Bank of America, Stifel, TD Cowen, Bernstein and RBC. Analysts Raise Agilent Technologies Price Targets
• Neutral Sentiment: Despite the improved outlook, valuation remains relatively demanding: Agilent trades at roughly 30 times earnings, with a PEG ratio above 2.7. This leaves the stock sensitive to any slowdown in demand or disappointment in future guidance.

Agilent Technologies Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company's product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source